In COVID-19, metabolic status changes, namely, the increased levels of circulating glucose and FFA, high levels of oxidative stress, and SIR (including IL-6, CRP), that are characteristic of pathologies associated with insulin resistance and correlates with the severity of the disease, may occur [133]. The gene discussed is IL6; the disease is COVID-19.